Literature DB >> 26838174

Flow-diverter devices in the treatment of intracranial aneurysms: A meta-analysis and systematic review.

Xianli Lv1, Hongchao Yang1, Peng Liu1, Youxiang Li2.   

Abstract

OBJECTIVE: The purpose of this report was to discuss the overall limitations, safety and efficacy of flow-diverter stenting for intracranial aneurysms.
METHODS: The authors performed a meta-analysis from January 2009 to September 2014 using the terms "flow diverter" and "intracranial aneurysms." Additional studies were identified through references in each reviewed article. Data extraction, performed independently by the authors, included demographic data, technical and clinical complications, morbidity and mortality, aneurismal occlusion rates related to flow-diverter devices. The analysis was performed using a fixed effect.
RESULTS: Twenty-nine studies with 1524 patients and three to 62 months of follow-up were identified for analysis. The overall technical failure and complication rate was 9.3% (95% CI 6%-12.6%). The rate of procedure-related complication was 14% (95% CI 10.2%-17.9%) and 6.6% (95% CI 4%-9.1%) for morbidity and mortality. Fusiform, dissecting and circumferential aneurysm (OR 3.10, 95% CI 0.93-10.37) were significant risk factors for technical failure and complication. Posterior circulation location (OR 4.03, 95% CI 2.45-6.61), peripheral location (OR 2.74, 95% CI 1.52-4.94) and fusiform, dissecting and circumferential aneurysm (OR 1.95, 95% CI 1.15-3.30) were statistically significant risk factors for procedure-related complications. Posterior circulation location (OR 4.39, 95% CI 2.44-7.90) and peripheral location (OR 3.64, 95% CI 1.74-7.62) were statistically significant risk factors for morbidity and mortality.
CONCLUSIONS: Fusiform, dissecting and circumferential aneurysm, posterior circulation and peripheral locations have greater procedure-related complications.
© The Author(s) 2016.

Entities:  

Keywords:  Intracranial aneurysm; endovascular treatment; flow-diverter stenting

Mesh:

Year:  2016        PMID: 26838174      PMCID: PMC4978339          DOI: 10.1177/1971400915621321

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  43 in total

1.  Treatment of intra-cranial aneurysms with the SILK flow diverter: 2 years' experience with 28 patients at a single center.

Authors:  Shimon Maimon; Lior Gonen; Erez Nossek; Ido Strauss; Ronen Levite; Zvi Ram
Journal:  Acta Neurochir (Wien)       Date:  2012-03-09       Impact factor: 2.216

2.  Flow-diverter silk stent for the treatment of intracranial aneurysms: 1-year follow-up in a multicenter study.

Authors:  J Berge; A Biondi; P Machi; H Brunel; L Pierot; J Gabrillargues; K Kadziolka; X Barreau; V Dousset; A Bonafé
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-02       Impact factor: 3.825

3.  Pipeline flow-diverter stent for endovascular treatment of intracranial aneurysms: preliminary experience in 20 patients with 27 aneurysms.

Authors:  Boris Lubicz; Laurent Collignon; Gaï Raphaeli; Olivier De Witte
Journal:  World Neurosurg       Date:  2011 Jul-Aug       Impact factor: 2.104

4.  Endovascular treatment using stents for vertebral artery fusiform aneurysms.

Authors:  Xianli Lv; Youxiang Li; Chuhan Jiang; Xinjian Yang; Zhongxue Wu
Journal:  Neurol Res       Date:  2010-05-04       Impact factor: 2.448

5.  Treatment of cavernous sinus aneurysms with flow diversion: results in 44 patients.

Authors:  R C Puffer; M Piano; G Lanzino; L Valvassori; D F Kallmes; L Quilici; H J Cloft; E Boccardi
Journal:  AJNR Am J Neuroradiol       Date:  2013-12-19       Impact factor: 3.825

6.  Treatment of intracranial aneurysms using the pipeline flow-diverter embolization device: a single-center experience with long-term follow-up results.

Authors:  I Saatci; K Yavuz; C Ozer; S Geyik; H S Cekirge
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-19       Impact factor: 3.825

7.  Endovascular treatment of cranial aneurysms with the pipeline flow-diverting stent: preliminary mid-term results.

Authors:  Celal Çinar; Halil Bozkaya; Ismail Oran
Journal:  Diagn Interv Radiol       Date:  2013 Mar-Apr       Impact factor: 2.630

8.  High-profile flow diverter (silk) implantation in the basilar artery: efficacy in the treatment of aneurysms and the role of the perforators.

Authors:  Zsolt Kulcsár; Ulrike Ernemann; Stephan G Wetzel; Alexander Bock; Sophia Goericke; Vasilis Panagiotopoulos; Michael Forsting; Daniel A Ruefenacht; Isabel Wanke
Journal:  Stroke       Date:  2010-07-08       Impact factor: 7.914

9.  Treatment of 14 intracranial aneurysms with the FRED system.

Authors:  Orlando Diaz; Taylor L Gist; Ginna Manjarez; Fernando Orozco; Rafael Almeida
Journal:  J Neurointerv Surg       Date:  2013-09-23       Impact factor: 5.836

10.  Midterm and long-term follow-up of cerebral aneurysms treated with flow diverter devices: a single-center experience.

Authors:  Mariangela Piano; Luca Valvassori; Luca Quilici; Guglielmo Pero; Edoardo Boccardi
Journal:  J Neurosurg       Date:  2012-11-23       Impact factor: 5.115

View more
  24 in total

1.  Patency of anterior choroidal artery after flow diverter deployment with assessment of magnetic resonance imaging follow-up.

Authors:  Takashi Fujii; Hidenori Oishi; Kohsuke Teranishi; Kenji Yatomi; Munetaka Yamamoto; Hajime Arai
Journal:  Neuroradiol J       Date:  2018-12-03

2.  Filament inadequate wall apposition of the different ends of flow diverters in the abdominal aorta of rabbits.

Authors:  Kuizhong Wang; Peng Jin; Peigang Lu; Qiang Liu; Bo Li; Zhenqiang Hao
Journal:  Neuroradiol J       Date:  2019-11-27

3.  Pipeline embolisation device with shield technology for the treatment of ruptured intracranial aneurysm.

Authors:  Christopher R Pasarikovski; Ghouth Waggass; Jillian Cardinell; Peter Howard; Leodante da Costa; Victor Xd Yang
Journal:  Neuroradiol J       Date:  2019-03-06

4.  The pressure reduction coefficient: A new parameter to assess aneurysmal blood stasis induced by flow diverters/disruptors.

Authors:  Gregory Gascou; Riccardo Ferrara; Dominique Ambard; Mathieu Sanchez; Kyriakos Lobotesis; Franck Jourdan; Vincent Costalat
Journal:  Interv Neuroradiol       Date:  2016-12-05       Impact factor: 1.610

5.  Management of Unruptured Saccular Aneurysms of the M1 Segment with Flow Diversion : A Single Centre Experience.

Authors:  Pervinder Bhogal; Rosa Martinez; Oliver Gansladt; Hansjörg Bäzner; Hans Henkes; Marta Aguilar
Journal:  Clin Neuroradiol       Date:  2016-12-11       Impact factor: 3.649

6.  A novel treatment of a patient with a giant ruptured middle cerebral artery aneurysm by acute coiling followed by scheduled Pipeline flex placement.

Authors:  Shikai Liang; Ren Yuan; Xianli Lv
Journal:  Neuroradiol J       Date:  2020-07-16

7.  The use of single low-profile visualized intraluminal support stent-assisted coiling in the treatment of middle cerebral artery bifurcation unruptured wide-necked aneurysm.

Authors:  Yazhou Yan; Zhangwei Zeng; Yina Wu; Jiachao Xiong; Kaijun Zhao; Bo Hong; Yi Xu; Jianmin Liu; Qinghai Huang
Journal:  Interv Neuroradiol       Date:  2020-01-24       Impact factor: 1.610

8.  Complex cerebral aneurysms: intra-luminal reconstruction using Pipeline flow-diverting stent and the obliteration mechanism.

Authors:  Xianli Lv; Chuhan Jiang; Zhongxue Wu; Weijian Jiang; Guihuai Wang
Journal:  Neuroradiol J       Date:  2019-12-11

9.  Unruptured giant intracavernous aneurysms untolerate internal carotid artery occlusion test: Untreated and treated with flow-diversion.

Authors:  Xianli Lv; Jianjun Yu; Ting Liao; Jin Wang; Guihuai Wang
Journal:  Neuroradiol J       Date:  2020-01-17

10.  Transcirculation Silk Vista Baby-assisted coiling in half-T configuration for the treatment of posterior communicating artery aneurysms associated with a fetal posterior circulation: An alternative flow diversion strategy.

Authors:  Mario Martínez-Galdámez; Miguel Schüller-Arteaga; Jorge Galván-Fernández; Vladimir Kalousek; Ezequiel Petra; Boris Pabón; Santiago Ortega-Gutiérrez; Paloma Jiménez-Arribas; Carlos Rodríguez-Arias
Journal:  Interv Neuroradiol       Date:  2020-09-23       Impact factor: 1.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.